Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4788307
Max Phase: Preclinical
Molecular Formula: C31H33NO6S
Molecular Weight: 547.67
Molecule Type: Unknown
Associated Items:
ID: ALA4788307
Max Phase: Preclinical
Molecular Formula: C31H33NO6S
Molecular Weight: 547.67
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C1C[C@]23C=C(Sc4ccccc4C)C(=O)[C@@](C)(CCC(=O)Nc4c(O)ccc(C(=O)O)c4O)[C@@H]2C[C@H]1CC3
Standard InChI: InChI=1S/C31H33NO6S/c1-17-6-4-5-7-22(17)39-23-16-31-13-10-19(18(2)15-31)14-24(31)30(3,28(23)36)12-11-25(34)32-26-21(33)9-8-20(27(26)35)29(37)38/h4-9,16,19,24,33,35H,2,10-15H2,1,3H3,(H,32,34)(H,37,38)/t19-,24+,30+,31-/m1/s1
Standard InChI Key: WOHXJLQPBUBGHW-CKXMXMCGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 547.67 | Molecular Weight (Monoisotopic): 547.2029 | AlogP: 6.45 | #Rotatable Bonds: 7 |
Polar Surface Area: 123.93 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.96 | CX Basic pKa: | CX LogP: 6.62 | CX LogD: 3.14 |
Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.23 | Np Likeness Score: 1.25 |
1. Li Y,Weng X,Deng Y,Pan J,Zhu S,Wen Z,Yuan Y,Li S,Shen B,Duan Y,Huang Y. (2021) Semisynthesis and Biological Evaluation of Platencin Thioether Derivatives: Dual FabF and FabH Inhibitors against MRSA., 12 (3.0): [PMID:33738071] [10.1021/acsmedchemlett.0c00653] |
Source(1):